Decompressive craniectomy combined with mild hypothermia in patients with large hemispheric infarction: a randomized controlled trial
Authors:
Open Access
- 12 March 2021
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-8
Abstract
Background: The effect of hypothermia on large hemispheric infarction (LHI) remains controversial. Our study aimed to explore the therapeutic outcomes of decompressive craniectomy (DC) combined with hypothermia on LHI. Methods: Patients were randomly divided into three groups: the DC group, the DC plus head surface cooling (DCSC) group and the DC plus endovascular hypothermia (DCEH) group. The DC group was maintained normothermia. The DCSC group received 24-h ice cap on the head for 7 days. While the DCEH group were given endovascular hypothermia (34 °C). Mortality and modified Rankin Scale (mRS) score at 6 months were evaluated. Results: Thirty-four patients were included in the study. Mortality of the DC, DCSC and DCEH groups at discharge were 22.2% (2/9), 0% (0/14) and 9.1% (1/11), respectively. However, it increased to 44.4% (4/9), 21.4% (3/14) and 45.5% (5/11) at 6 months, respectively (p = 0.367). Pneumonia (8 cases) was the leading cause of death after discharge. Twelve cases (35.3%) achieved good neurological outcome (mRS 0–3) at 6 months. The proportions of good neurological outcome in the DC, DCSC and DCEH groups were 22.2% (2/9 cases), 42.9% (6/14 cases) and 36.4% (4/11), respectively. The DCSC group seemed to have higher proportion of good outcomes, but there was no significant difference between groups (p = 0.598). Among survivors, endovascular hypothermia had a higher proportion of good outcome (DC group, 2/5 cases, 40.0%; DCSC group, 6/11 cases, 54.5%; DCEH group, 4/6 cases, 66.7%; p = 0.696). The incidence of complications in the DCEH group was higher than those of the DC and DCSC groups (18.9%, 12.0%, and 12.1%, respectively; p = 0.025). Conclusions: There is still no evidence to confirm that hypothermia further reduces long-term mortality and improves neurological outcomes in LHI patients with DC. However, there is a trend to benefit survivors from hypothermia. A local cooling method may be a better option for DC patients, which has little impact on systematic complications. Trial registration: Decompressive Hemicraniectomy Combined Hypothermia in Malignant Middle Cerebral Artery Infarct, ChiCTR-TRC-12002698. Registered 11 Oct 2012- Retrospectively registered, URL: http://www.chictr.org.cn/showproj.aspx?proj=6854.Keywords
All Related Versions
Funding Information
- National Key Clinical Specialty Discipline Construction Program of China
This publication has 27 references indexed in Scilit:
- Outcomes of Hypothermia in Addition to Decompressive Hemicraniectomy in Treatment of Malignant Middle Cerebral Artery StrokeJAMA Neurology, 2019
- Safety and Efficacy of Hypothermia (34°C) after Hemicraniectomy for Malignant MCA InfarctionJournal of Korean Neurosurgical Society, 2018
- Glibenclamide enhances the effects of delayed hypothermia after experimental stroke in ratsBrain Research, 2016
- Improved Neurological Outcome With Mild Hypothermia in Surviving Patients With Massive Cerebral Hemispheric InfarctionStroke, 2016
- Surgical Decompression for Space-Occupying Cerebral InfarctionStroke, 2013
- Decompressive Hemicraniectomy in Malignant Middle Cerebral Artery Infarct: A Randomized Controlled Trial Enrolling Patients up to 80 Years OldNeurocritical Care, 2012
- Adjunctive Functional Pharyngeal Electrical Stimulation Reverses Swallowing Disability After Brain LesionsGastroenterology, 2010
- Glibenclamide Is Superior to Decompressive Craniectomy in a Rat Model of Malignant StrokeStroke, 2010
- Effects of Hypothermia on Energy Metabolism in Mammalian Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2003
- 'Malignant' Middle Cerebral Artery Territory InfarctionArchives of Neurology, 1996